🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to describe quality of life in hereditary or acquired non d...
Status
Completed
Location
CHU Besançon
Start Date
2016-07-11
Trial ID
NCT03240991
Treatments Being Tested
Fire-fighters are at increased risk of death from heart attacks when compar...
Status
Completed
Location
Royal Infirmary of Edinburgh Clinical Research Facility
Start Date
2012-04
Trial ID
NCT01812317
Treatments Being Tested
Heart attacks are usually caused by a blood clot blocking an artery supplyi...
Status
Completed
Location
University of Edinburgh, 49 Little France Crescent
Start Date
2009-08
Trial ID
NCT00965120
Treatments Being Tested
This is an expanded access program (EAP) designed to allow access to deucri...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT07759141
Treatments Being Tested
In the light of ONTARGET and TRANSCEND studies results, it would be interes...
Status
Completed
Location
Multiple Locations
Start Date
2009-05
Trial ID
NCT01211171
Treatments Being Tested
T-PA release is impaired in obese subjects. In order to have a better mecha...
Status
Terminated
Location
Vanderbilt University Medical Center
Start Date
2007-01
Trial ID
NCT00780481
Treatments Being Tested
ANCA-associated vasculitis is an autoimmune disease that causes damage to b...
Status
Active Not Recruiting
Location
Centre for Cardiovascular Science, Queen's Medical Research Institute, 47 Little France Crescent
Start Date
2022-12-08
Trial ID
NCT05630612
Treatments Being Tested
Bradykinin stimulates t-PA release from intact vessels, but not from endoth...
Status
Withdrawn
Location
Vanderbilt University Medical Center
Start Date
2008-10
Trial ID
NCT00780637
Treatments Being Tested
The unpredictable nature of the attacks is one of the essential characteris...
Status
Terminated
Location
Hop Claude Huriez Chu Lille
Start Date
2022-01-22
Trial ID
NCT04963634
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of Icatibant...
Status
Completed
Location
Georgetown University Hospital, Lombardi Cancer Center
Start Date
2004-12-28
Trial ID
NCT00097695